Kimberly Sakai

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Emma Morton, Kimberly Sakai, Amir Ashtari et al. · Journal of Psychopharmacology · 2022 · 72 citations · Full text

Medicine, Psychiatry, Psychology +15

“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

Meghan DellaCrosse, Mollie Pleet, Emma Morton et al. · PLoS ONE · 2022 · 27 citations · Full text

Medicine, Psychiatry, Psychology +14

Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial

Ellen Bradley, Kimberly Sakai, Gisele Fernandes‐Osterhold et al. · Neuropsychopharmacology · 2025 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16